Sinan Yavuz

Prof. Sinan Yavuz is an experienced medical oncologist with a strong academic and clinical background. He earned his medical degree and achieved the title of Associate Professor in 2006 from Çukurova University Faculty of Medicine. Since 2014 he has been affiliated with Acıbadem Health Group, contributing to patient care and oncology services. He is an active member of the Turkish Medical Association, the Turkish Oncology Group, and the European Society for Medical Oncology (ESMO). His work blends academic knowledge with practical clinical experience in oncology, focused on delivering evidence-based care and advancing cancer treatment in Turkey.

Education

• 2006 Çukurova University Faculty of Medicine / Associate Professor
• 2006 Cukurova University Faculty of Medicine Medical Oncology
• 2000 Çukurova University Faculty of Medicine, Department of Internal Medicine / Assistant Professor
• 2000 Çukurova University Faculty of Medicine Internal Medicine
• 1995 Cukurova University Faculty of Medicine

Experience

• 2014 Acibadem Health Group
• 2000 – 2009 Çukurova University Department of Medical Oncology
• 1995 – 2000 Çukurova University Department of Internal Medicine

Memberships

• Turkish Medical Association.
• Turkish Oncology Group.
• ESMO (European Society For Medical Oncology.)

Publications

• IDA-Flag Regimen for the Therapy of Primary Refractory and Relapsed Acute Leukemia: A Single Center Experience.
  Am J Ther, 13 (5), 389-393 (2006). Yavuz, S., S. Paydas, U. Disel, B. Sahin.
• VEGF-C Expression in Breast Cancer: Clinical Importance.
  Adv Ther, 22 (4), 368-380 (2005). Yavuz, S., S. Paydas, S. Zorludemir, S. Erdogan, U. Disel.
• Ovarian Granulocytic Sarcoma.
  Leuk Lymphoma, 45(1), 183-185 (2004). Yavuz, S., S. Paydas, U. Disel, S. Erdogan.
• Prostatic Hypertrophy and Prostatic Infiltration in Small Lymphocytic Lymphoma.
  Leuk Lymphoma, 45(1), 201-202 (2004). Yavuz, S., S. Paydas, U. Disel, S. Zorludemir, S. Erdogan.
• Hepatitis B Virus Reactivation During Fludarabine Therapy in Non-Hodgkins Lymphoma.
  Leuk Lymphoma, 44(7), 1249-1250, (2003). Yavuz, S., S. Paydas, U. Disel, B. Sahin.